ALIG — Alimak AB (publ) Income Statement
0.000.00%
- SEK12.02bn
- SEK14.40bn
- SEK6.87bn
Annual income statement for Alimak AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,728 | 4,512 | 7,097 | 7,099 | 6,874 |
| Cost of Revenue | |||||
| Gross Profit | 1,272 | 1,593 | 2,820 | 2,851 | 2,760 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,280 | 3,966 | 6,152 | 6,101 | 5,897 |
| Operating Profit | 448 | 546 | 945 | 998 | 977 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 410 | 485 | 681 | 810 | 810 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 308 | 376 | 516 | 623 | 604 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 308 | 376 | 516 | 623 | 604 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 308 | 376 | 515 | 623 | 604 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.24 | 5.04 | 4.82 | 5.96 | 5.97 |
| Dividends per Share |